BioPlus Acquisition Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

R. Ross Haghighat

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	no data
CEO ownership	n/a
Management average tenure	no data
Board average tenure	no data

Recent management updates

No updates

Recent updates

CEO

R. Ross Haghighat (59 yo)

no data

Tenure

Mr. R. Ross Haghighat serves as the Chief Executive Officer of Elecon, Inc. He serves as Chairman of the Board at FRX Innovations Inc. Mr. Haghighat is Managing Partner of Triton Systems, Inc., and Newbury...

BioPlus Acquisition Management

Management criteria checks 0/4

Key information

Recent management updates

Recent updates

BioPlus Acquisition Corp. Files Form 15

BioPlus Acquisition Corp.(NasdaqGM:BIOS) dropped from NASDAQ Composite Index

Avertix Medical, Inc. terminated the acquisition of BioPlus Acquisition Corp. (NasdaqGM:BIOS) from BioPlus Sponsor LLC, Highbridge Capital Management, LLC, Saba Capital Management, L.P., Cantor Fitzgerald & Co, Investment Arm and others in a reverse merger transaction.

BioPlus Acquisition Corp. (NasdaqGM:BIOS) entered into a definitive merger agreement to acquire Avertix, Inc. for approximately $170 million.

CEO

Tenure